Development of Selective Covalent Janus Kinase 3 Inhibitors
Li Tan(Shanghai Institute of Organic Chemistry), Nathanael S. Gray(Stanford University)
Cited by 115
Related Papers
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
|Journal of Biological Chemistry|2009|1.8k
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
|Nature Chemical Biology|2016|368
Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216
|Journal of Medicinal Chemistry|2021|55
Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer
|Cancer Research|2022|55